Inferensys

Glossary

Model Cards

Structured transparency documents that report the intended use, evaluation results, and ethical considerations of a trained machine learning model.
Stylish WeWork-like workspace with hot desks and document wall, professional searching through enterprise knowledge base on a mounted ultrawide display, warm industrial pendants overhead.
TRANSPARENCY DOCUMENTATION

What Are Model Cards?

A model card is a structured transparency document that reports the intended use, evaluation results, and ethical considerations of a trained machine learning model.

A model card is a short, structured document accompanying a trained machine learning model that discloses its intended use context, performance evaluation metrics across different demographic or environmental slices, and known ethical limitations. Originating from a 2019 Google research paper, model cards standardize how developers report a model's fairness, robustness, and out-of-scope applications to downstream users.

For FDA submission teams and clinical decision support developers, model cards serve as a critical governance artifact, summarizing SHAP value analyses and attention visualization results to demonstrate algorithmic explainability. They typically include disaggregated evaluation tables, detailing how a diagnostic model performs across patient subgroups defined by age, sex, or comorbidity, thereby supporting regulatory review of Good Machine Learning Practice (GMLP) compliance.

STRUCTURED TRANSPARENCY

Core Characteristics of Model Cards

Model cards are short, structured documents that accompany trained machine learning models to provide essential context on their intended use, performance characteristics, and limitations.

01

Intended Use and Out-of-Scope Applications

A model card must explicitly define the use cases for which the model was designed and validated, as well as out-of-scope applications where performance is untested or likely to fail. This section prevents dangerous off-label deployment.

  • Specifies target patient populations, imaging modalities, or data types
  • Enumerates known failure modes and demographic exclusions
  • Distinguishes between primary and secondary intended uses per FDA guidance
02

Evaluation Results and Performance Metrics

This section reports quantitative performance across relevant evaluation datasets, broken down by meaningful subgroups to surface hidden disparities. It moves beyond aggregate accuracy to reveal where a model underperforms.

  • Reports sensitivity, specificity, AUC, and PPV for diagnostic models
  • Includes slice-based analysis across age, sex, and race strata
  • Documents the evaluation dataset's provenance, size, and labeling methodology
03

Ethical Considerations and Fairness Analysis

Model cards require a candid assessment of ethical risks, including potential biases and disparate impacts. This section demonstrates that developers have proactively interrogated their model for harm before release.

  • Documents fairness metrics such as equal opportunity difference
  • Describes mitigation strategies applied during training or post-processing
  • Acknowledges limitations in the fairness analysis itself
04

Training Data and Methodology

Transparency about the training data's composition, collection process, and preprocessing allows downstream users to assess representativeness and potential distribution shift. This section provides the provenance necessary for auditability.

  • Describes data sources, inclusion criteria, and annotation procedures
  • Reports demographic distributions and known gaps in coverage
  • Summarizes the model architecture, training objective, and hyperparameters
05

Caveats, Limitations, and Maintenance

Every model card must honestly communicate what the model cannot do and under what conditions its predictions become unreliable. This section also addresses the model's lifecycle and update cadence.

  • Warns against distribution shift and concept drift over time
  • Specifies environmental constraints such as input resolution or format
  • Indicates the versioning policy and planned retraining schedule
MODEL CARDS

Frequently Asked Questions

Clear, concise answers to the most common questions about structured transparency documents for machine learning models.

A model card is a structured transparency document that reports the intended use, evaluation results, and ethical considerations of a trained machine learning model. Introduced by Google Research in 2019, model cards serve as a standardized disclosure mechanism that communicates a model's capabilities, limitations, and performance characteristics across different demographic groups and evaluation conditions. Their importance lies in enabling informed decision-making by downstream users, facilitating regulatory compliance, and promoting accountability in AI development. For clinical diagnostic systems, model cards provide FDA submission teams with a concise summary of how a model was validated, on what populations it was tested, and under what conditions its predictions remain reliable, directly supporting the Good Machine Learning Practice (GMLP) framework.

TRANSPARENCY DOCUMENTATION COMPARISON

Model Cards vs. Other Documentation Artifacts

A comparison of structured transparency artifacts used to document machine learning models, their intended use, and performance characteristics for regulatory and ethical review.

FeatureModel CardsDatasheets for DatasetsSystem CardsAlgorithmic Impact Assessments

Primary focus

Trained model reporting

Dataset documentation

System-level transparency

Societal risk evaluation

Intended audience

Developers, auditors, end-users

Data scientists, researchers

Policymakers, general public

Regulators, ethics boards

Reports evaluation results

Disaggregated performance metrics

Ethical considerations section

Intended use and limitations

Training data provenance

Regulatory alignment

FDA GMLP, EU AI Act

GDPR, data governance

EU AI Act transparency

NIST AI RMF, impact laws

Prasad Kumkar

About the author

Prasad Kumkar

CEO & MD, Inference Systems

Prasad Kumkar is the CEO & MD of Inference Systems and writes about AI systems architecture, LLM infrastructure, model serving, evaluation, and production deployment. Over 5+ years, he has worked across computer vision models, L5 autonomous vehicle systems, and LLM research, with a focus on taking complex AI ideas into real-world engineering systems.

His work and writing cover AI systems, large language models, AI agents, multimodal systems, autonomous systems, inference optimization, RAG, evaluation, and production AI engineering.